<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd"
	xmlns:media="http://search.yahoo.com/mrss/"
	>
<channel>
	<title>Comments on: Blind Ambition &#8211; DTC Perspectives Day 1</title>
	<atom:link href="http://blog.pharmexec.com/2008/10/30/blind-ambition/feed/" rel="self" type="application/rss+xml" />
	<link>http://blog.pharmexec.com/2008/10/30/blind-ambition/</link>
	<description>The Business of Pharmaceuticals</description>
	<lastBuildDate>Wed, 08 Feb 2012 14:53:10 -0500</lastBuildDate>
	
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: From PharmExec Blog: Blind Ambition (social media and pharma marketeers) &#171; Arthur Alston&#8217;s MetaBlog</title>
		<link>http://blog.pharmexec.com/2008/10/30/blind-ambition/comment-page-1/#comment-20318</link>
		<dc:creator>From PharmExec Blog: Blind Ambition (social media and pharma marketeers) &#171; Arthur Alston&#8217;s MetaBlog</dc:creator>
		<pubDate>Thu, 27 Nov 2008 22:07:21 +0000</pubDate>
		<guid isPermaLink="false">http://blog.pharmexec.com/?p=398#comment-20318</guid>
		<description>[...] PharmExec Blog: Blind Ambition (social media and pharma&#160;marketeers) November 28, 2008     Blind Ambition  PharmExec Blog 10/31/08 Andy Levitt  [...]</description>
		<content:encoded><![CDATA[<p>[...] PharmExec Blog: Blind Ambition (social media and pharma&nbsp;marketeers) November 28, 2008     Blind Ambition  PharmExec Blog 10/31/08 Andy Levitt  [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Distractions Abound - DTC Perspectives Day 2</title>
		<link>http://blog.pharmexec.com/2008/10/30/blind-ambition/comment-page-1/#comment-19541</link>
		<dc:creator>Distractions Abound - DTC Perspectives Day 2</dc:creator>
		<pubDate>Fri, 31 Oct 2008 18:16:18 +0000</pubDate>
		<guid isPermaLink="false">http://blog.pharmexec.com/?p=398#comment-19541</guid>
		<description>[...] couldn&#8217;t help but think more about what Mike Bloxham had said yesterday when he highlighted the inherent challenges of reaching consumers with traditional advertising. He [...]</description>
		<content:encoded><![CDATA[<p>[...] couldn&#8217;t help but think more about what Mike Bloxham had said yesterday when he highlighted the inherent challenges of reaching consumers with traditional advertising. He [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Andy Levitt</title>
		<link>http://blog.pharmexec.com/2008/10/30/blind-ambition/comment-page-1/#comment-19531</link>
		<dc:creator>Andy Levitt</dc:creator>
		<pubDate>Fri, 31 Oct 2008 04:13:18 +0000</pubDate>
		<guid isPermaLink="false">http://blog.pharmexec.com/?p=398#comment-19531</guid>
		<description>Hi Joe - thanks for your comment and for sharing your perspective.  I chose Eons as an example because it matches the age demographic of most executives who have yet to ever try a social network.  Perhaps they will see it as an example of a site that other boomers may use for social media.  I have no affiliation with Eons, and I guess we&#039;ll see how long they survive.</description>
		<content:encoded><![CDATA[<p>Hi Joe &#8211; thanks for your comment and for sharing your perspective.  I chose Eons as an example because it matches the age demographic of most executives who have yet to ever try a social network.  Perhaps they will see it as an example of a site that other boomers may use for social media.  I have no affiliation with Eons, and I guess we&#8217;ll see how long they survive.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Joe</title>
		<link>http://blog.pharmexec.com/2008/10/30/blind-ambition/comment-page-1/#comment-19523</link>
		<dc:creator>Joe</dc:creator>
		<pubDate>Thu, 30 Oct 2008 20:51:16 +0000</pubDate>
		<guid isPermaLink="false">http://blog.pharmexec.com/?p=398#comment-19523</guid>
		<description>C&#039;mon - eons.com?  Have you seen their traffic or recent articles about how small their staff has become.  If you are going to advocate learning about social networking, it might help to only reference sites that have a chance of being around.</description>
		<content:encoded><![CDATA[<p>C&#8217;mon &#8211; eons.com?  Have you seen their traffic or recent articles about how small their staff has become.  If you are going to advocate learning about social networking, it might help to only reference sites that have a chance of being around.</p>
]]></content:encoded>
	</item>
</channel>
</rss>

